(Q51729292)

English

Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.

scientific article published on 5 November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

2

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

author name string

Remberger M

1

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

Hassan Z

3

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

Karlsson N

4

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

LeBlanc K

5

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

Omazic B

6

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

Okas M

7

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

Sairafi D

8

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

Ringdén O

9

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

language of work or name

0 references

publication date

5 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

41

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

4

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

399-405

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705913

0 references

Strategies to reduce transplant-related mortality after allogeneic stem cell transplantation in elderly patients: Comparison of reduced-intensity conditioning and unmanipulated peripheral blood stem cells vs a myeloablative regimen and CD34+ cell se

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

Definitions of cytomegalovirus infection and disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

A Proportional Hazards Model for the Subdistribution of a Competing Risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

21 January 2018

Risk factors for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

7 January 2021

based on heuristic

inferred from DOI database lookup

Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

7 January 2021

based on heuristic

inferred from DOI database lookup

No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

7 January 2021

based on heuristic

inferred from DOI database lookup

ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705913

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705913

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/17982493

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51729292&oldid=1465445341"